Based on these initial promising results, the concept of radioguided lymphadenectomy in early recurrent prostate cancer patients using [111In]PSMA-I&T as a PSMA-targeted intraoperative probe has recently been further pursued [10, 11]. This evidence concerns the gene FOLH1 and prostate cancer.